OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
13.18
-0.18 (-1.35%)
Dec 15, 2025, 4:00 PM EST - Market closed
OptimizeRx Stock Forecast
Stock Price Forecast
The 6 analysts that cover OptimizeRx stock have a consensus rating of "Buy" and an average price target of $14.83, which forecasts a 12.52% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $24.
Price Target: $14.83 (+12.52%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for OptimizeRx stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Hold Maintains $20 → $17 | Hold | Maintains | $20 → $17 | +28.98% | Nov 17, 2025 |
| Citizens | Citizens | Buy Maintains $23 → $24 | Buy | Maintains | $23 → $24 | +82.09% | Nov 7, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $20 → $23 | Buy | Maintains | $20 → $23 | +74.51% | Oct 10, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $14 → $20 | Buy | Maintains | $14 → $20 | +51.75% | Aug 11, 2025 |
| Stifel | Stifel | Strong Buy Maintains $16 → $18 | Strong Buy | Maintains | $16 → $18 | +36.57% | Aug 8, 2025 |
Financial Forecast
Revenue This Year
110.34M
from 92.13M
Increased by 19.77%
Revenue Next Year
122.84M
from 110.34M
Increased by 11.33%
EPS This Year
0.76
from -1.10
EPS Next Year
0.90
from 0.76
Increased by 17.37%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 116.3M | 133.7M | |
| Avg | 110.3M | 122.8M | |
| Low | 104.6M | 110.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 26.3% | 21.2% | |
| Avg | 19.8% | 11.3% | |
| Low | 13.5% | 0.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.81 | 1.08 | |
| Avg | 0.76 | 0.90 | |
| Low | 0.70 | 0.71 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 41.7% | |
| Avg | - | 17.4% | |
| Low | - | -7.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.